Spectra Optia

Innovation Type: Medical Device

Speciality: Vascular Access

Innovation Origin: NHS England MedTech Funding Mandate

The Spectra Optia Apheresis System is an apheresis and cell collection platform for the treatment of sickle cell disease.

In a typical exchange procedure, Spectra Optia separates and removes sickle red blood cells from the patient’s blood using continuous flow and centrifugation. These are replaced with healthy red blood cells according to the user-defined software protocol.

For more information, please visit: https://www.terumobct.com/spectra-optia

< Back to Innovation Finder

Contact us

If you'd like to discuss this Innovation, have an idea or a new Innovation, please get in touch.